Glycemic Index, Glycemic Control and Beyond

Author(s): Christos S. Derdemezis, Julie A. Lovegrove.

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 22 , 2014

Become EABM
Become Reviewer

Abstract:

It is currently estimated that over 370 million individuals have diabetes, making diabetes a major public health issue contributing significantly to global morbidity and mortality. The steep rise in diabetes prevalence over the past decades is attributable, in a large part, to lifestyle changes, with dietary habits and behaviour as significant contributors. Despite the relatively wide availability of antidiabetic medicine, it is lifestyle approaches that still remain the cornerstone of diabetes prevention and treatment. Glycemic index (GI) is a nutritional tool which represents the glycemic response to carbohydrate ingestion. In light of the major impact of nutrition on diabetes pathophysiology, with the rising need to combat the escalating diabetes epidemic, this review will focus on the role of GI in glycemic control, the primary target of diabetic treatment and beyond. The review will present the evidence relating GI and diabetes treatment and prevention, as well as weight loss, weight maintenance and cardiovascular disease risk factors.

Keywords: Glycemic index, glycemic control, diabetes and cardiovascular disease.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 20
ISSUE: 22
Year: 2014
Page: [3620 - 3630]
Pages: 11
DOI: 10.2174/13816128113196660670
Price: $58

Article Metrics

PDF: 28